Siga Technologies (SIGA) Non-Current Deferred Tax Liability (2010 - 2017)
Siga Technologies' (SIGA) quarterly Non-Current Deferred Tax Liability came in at $306449.0 in Q3 2017, up 8.71% on a YoY basis from $281889.0 in Q3 2016, and little changed quarter-over-quarter from $307256.0 in Q2 2017.
Analysis
Siga Technologies (SIGA) Non-Current Deferred Tax Liability (2010 - 2017) Analysis & Trends
Siga Technologies (SIGA) has reported Non-Current Deferred Tax Liability for 5 consecutive years, with $306449.0 the latest figure, recorded in Q3 2017.
- For the quarter ending Q3 2017, Non-Current Deferred Tax Liability rose 8.71% year-over-year to $306449.0; the trailing twelve-month figure through Sep 2017 stood at $306449.0 (up 8.71% YoY), and the FY2016 full-year result was $286066.0, up 7.69% from the prior year.
- Non-Current Deferred Tax Liability steadied at $306449.0 in Q3 2017 per SIGA's latest filing, from $307256.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $7.5 million in Q3 2015 and bottomed at $240973.0 in Q3 2014.
- Historically, Non-Current Deferred Tax Liability has averaged $1.8 million across 4 years, with a median of $286066.0 in 2016.
- The sharpest annual moves came in 2015 and 2016: Non-Current Deferred Tax Liability soared 3020.62% in 2015, then plunged 96.25% in 2016.
- Over 4 years, Non-Current Deferred Tax Liability stood at $244540.0 in 2014, then grew by 8.63% to $265643.0 in 2015, then advanced by 7.69% to $286066.0 in 2016, then gained by 7.13% to $306449.0 in 2017.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $306449.0, $307256.0, and $307256.0 for Q3 2017, Q2 2017, and Q1 2017 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 306,449.00 |
| Jun 30, 2017 | 307,256.00 |
| Mar 31, 2017 | 307,256.00 |
| Dec 31, 2016 | 286,066.00 |
| Sep 30, 2016 | 281,889.00 |
| Jun 30, 2016 | 277,088.00 |
| Mar 31, 2016 | 277,895.00 |
| Dec 31, 2015 | 265,643.00 |
| Sep 30, 2015 | 7.52 Mn |
| Jun 30, 2015 | 7.07 Mn |
| Mar 31, 2015 | 6.50 Mn |
| Dec 31, 2014 | 244,540.00 |
| Sep 30, 2014 | 240,973.00 |
| Dec 31, 2010 | 175,175.00 |